| Filed On | Filing |
|---|---|
| 09 Oct 2026 | FORM S-1 |
| 06 Oct 2026 | FORM DEFA14A |
| 06 Oct 2026 |
8-K: Submission of Matters to a Vote of Security Holders; Other Events
On September 3, 2026, BIO-key International, Inc. (the “Company”) convened its 2026 Annual Meeting of Stockholders (the “Annual Meeting”), which was adjourned until Friday, October 2, 2026 at 10:00 a.m., local time, at the Company’s offi... |
| 02 Oct 2026 |
8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities
THE EXCHANGE CONTEMPLATED HEREIN IS INTENDED TO COMPORT WITH THE REQUIREMENTS OF SECTION 3(a)(9) OF THE SECURITIES ACT OF 1933, AS AMENDED. |
| 08 Sep 2026 | FORM DEFA14A |
| 08 Sep 2026 |
8-K: Other Events
On September 3, 2026, BIO-key International, Inc. (the “Company”) convened its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders were requested to approve four proposals as desc... |
| 24 Aug 2026 | FORM DEFA14A |
| 14 Aug 2026 | FORM PRE 14A |
| 14 Aug 2026 | 8-K: Results of Operations and Financial Condition |
| 13 Aug 2026 | FORM 10-Q |
| 13 Aug 2026 | 8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities |
| 24 Jul 2026 | FORM ARS |
| 24 Jul 2026 |
Proxy statement: annual meeting on September 3, 2026
CEO pay $347K, up 12% · say-on-pay vote |
| 09 Jul 2026 | 8-K: Changes in Registrant's Certifying Accountant |
| 07 Jul 2026 | 8-K: Regulation FD Disclosure |
| 02 Jul 2026 |
Form 4: Sullivan James David, Chief Legal Officer
Received 250 shares as a grant or award ($958) |
| 02 Jul 2026 |
Form 4: Depasquale Michael W, Director
Received 250 shares as a grant or award ($958) |
| 02 Jul 2026 |
Form 4: Lacous Mira K, Chief Technology Officer
Received 250 shares as a grant or award ($958) |
| 22 Jun 2026 | FORM 10-Q |
| 15 Jun 2026 | FORM 10-K/A |
Loading...
